Analysen von James Gordon
| 13.03.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 27.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 02.02.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 18.01.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 15.01.18 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 29.12.17 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 12.12.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 08.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 07.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 02.11.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 06.10.17 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 31.03.16 | Roche overweight | JP Morgan Chase & Co. | |
| 08.12.15 | MorphoSys overweight | JP Morgan Chase & Co. | |